Pre-made Teprotumumab biosimilar ( Whole mAb, anti-IGF1R therapeutic antibody) - benchmark reference antibody
Cat No.: GMP-Bios-ab-564
Anti-IGF1R therapeutic antibody (Pre-made Teprotumumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
A recombinant, fully human monoclonal antibody directed against the insulin-like growth factor-1 receptor (IGF-1R) with potential antineoplastic activity.
Delivery impact due to the Coronavirus Outbreak
With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.
|Catalog No.||Package||Price(In USD)||Qty (Quantity)||Sum(In USD)|
|Products Name (INN Index)||Anti-IGF1R therapeutic antibody (Pre-made Teprotumumab biosimilar,Whole mAb)|
|Highest_Clin_Trial (Jan '20)||Approved|
|100% SI Structure||None|
|99% SI Structure||None|
|95-98% SI Structure||None|
|Companies||Genmab;Roche;Horizon Therapeutics plc|
|Conditions Approved||Graves ophthalmopathy|
|Conditions Active||Diffuse scleroderma|
|Conditions Discontinued||Diabetic macular oedema;Advanced breast cancer;Hodgkin's disease;Non-Hodgkin's lymphoma;Non-small cell lung cancer;Sarcoma;Solid tumours|
|Development Tech||Medarex UltiMAb Mouse|